Cinctive Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,000
Closed -$4.56M 557
2022
Q2
$4.56M Hold
50,000
0.19% 176
2022
Q1
$4.1M Buy
+50,000
New +$3.94M 0.15% 222
2021
Q4
Sell
-200,000
Closed -$15M 611
2021
Q3
$15M Buy
+200,000
New +$15.2M 0.74% 16

Other funds holding MRK

Cinctive Capital Management's MRK Position: Q1 2026 in Review

Cinctive Capital Management reduced its Merck (MRK) stake by 65% in Q1 2026, selling an estimated $3.58M and leaving 16,707 shares worth $2.01M. The position accounts for 0.13% of the portfolio, ranked #206.

Cinctive Capital Management first reported a position in MRK in Q3 2021 and has held it in 8 quarters since. The position peaked at $16.1M in Q3 2021. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cinctive Capital Management held 16,707 shares of Merck worth $2.01M as of Q1 2026.
  • Cinctive Capital Management sold 30,999 Merck shares in Q1 2026, an estimated $3.58M.
  • Merck made up 0.13% of Cinctive Capital Management's portfolio in Q1 2026, its #206 holding.
  • Cinctive Capital Management first reported a position in Merck in Q3 2021 and has held it in 8 quarters since.
  • Cinctive Capital Management's Merck position peaked at $16.1M in Q3 2021.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.